| Literature DB >> 32970818 |
Iwona Wojda1, Bernard Staniec2, Michał Sułek1, Jakub Kordaczuk1.
Abstract
The greater wax moth Galleria mellonella is an invertebrate that is increasingly being used in scientific research. Its ease of reproduction, numerous offspring, short development cycle, and finally, its known genome and immune-related transcriptome provide a convenient research model for investigation of insect immunity at biochemical and molecular levels. Galleria immunity, consisting of only innate mechanisms, shows adaptive plasticity, which has recently become the subject of intensive scientific research. This insect serves as a mini host in studies of the pathogenicity of microorganisms and in vivo tests of the effectiveness of single virulence factors as well as new antimicrobial compounds. Certainly, the Galleria mellonella species deserves our attention and appreciation for its contribution to the development of research on innate immune mechanisms. In this review article, we describe the biology of the greater wax moth, summarise the main advantages of using it as a model organism and present some of the main techniques facilitating work with this insect.Entities:
Keywords: zzm321990 Galleria mellonellazzm321990 ; host-pathogen interaction; insect immunity; insect model organism; life history
Year: 2020 PMID: 32970818 PMCID: PMC7683414 DOI: 10.1093/femspd/ftaa057
Source DB: PubMed Journal: Pathog Dis ISSN: 2049-632X Impact factor: 3.166
Figure 1.Systematics of G. mellonella and imago (photograph: M. Kucharczyk).
Figure 2.Abandoned beehive inhabited by G. mellonella: pupal cocoons (p) found outside beehive (A); waxes affected by galleriosis (indicated by the arrow in (B)) and magnification thereof (C): eggs (e) and silk (s) on the wax (photograph: G. K. Wagner).
Figure 3.Morphology of G. mellonella larvae. Dorsal (I), ventral (II) and lateral (III) view of a G. mellonella larva. A - sclerotised head with lateral stemmata, B - thorax, C - abdomen, D - antennae, E - chewing mouthparts, F - pair of thoracic legs, G - claw, H - pair of prolegs, I - anal prolegs, J - prothorax spiracle, K - abdominal spiracle, L - spiracle of abdominal segment VIII (the largest of all).
G. mellonella humoral effectors.
| Proteins involved in microbial clearance | Proteins involved in melanisation, coagulation and wound healing |
|---|---|
| Anionic peptide-1 | Alfa-crystallin |
| Anionic peptide-2 | Arylophorin |
| Apolipophorin-III | |
| Cecropin A | Glutathione-S-transferase-like protein |
| Cecropin D | |
| Defensin | Plasmatocyte spreading peptide |
| Galiomycin | Prophenoloxidase (Phenoloxidase) |
| Gallysin | |
| Gloverin | |
| Heliocin-like peptide | Lipophorines |
| Induced inhibitor of serine proteases-1 | Apolipophorin-I |
| Induced inhibitor of serine proteases-2 | Apolipophorin-II |
| Induced inhibitor of serine proteases-3 | Apolipophorin-III |
| Insect metalloprotease inhibitor | Transglutaminase |
| Lysozyme | |
| Moricin-like peptide A1, | |
| Moricin-like peptide B1, | |
| Moricin like peptide C4/C51, | |
| Moricin-like peptide C1/C2/C31, | |
| Moricin-like peptides D1, | |
| Proline-rich peptide-1 | |
| Proline-rich peptide-2 | |
| 6-tox protein | |
| Phipps, Chadwick and Aston | Rowley and Ratcliffe |
antimicrobial peptide with direct antimicrobial activity.
inhibitors of microbial enzymes.
IMPI-the first peptidic specific inhibitor of metalloproteinases found in animals.
may act non-enzymatically as AMP (antimicrobial peptide) and enzymatically (muramidase).
found only in Lepidoptera; in some cases the protein products of different genes are the same.
small heat shock protein, cellular coagulogen.
hexamerin, humoral coagulogen.
cellular coagulogen.
peptide secreted by hemocytes, attracting other hemocytes to the encapsulation/nodulation site.
zymogen of phenol oxidase, catalysing melanin synthesis.
proteins engaged in lipid transport, serving also as humoral coagulogens.
enzyme catalysing formation of isopeptidic bonds during coagulation.
Figure 4.Methods for experimental infection of G. mellonella larvae. Force feeding (A, B). The needle (capillary) needs to be inserted accurately and gently into the larval mouth hole without wounding the larvae and an exact volume must be introduced and ingested by the larva. Infection through the cuticle can be done by placing the larva on the filter paper and washing with a water-containing desired concentration of fungal spores (C and D) or by placing the larvae on a plate with sporulated fungus (for example, B. bassiana) and gently rolling (E). Microorganisms can also be introduced directly into the hemocel with the use of a needle introduced into the last or last-but-one proleg (F, G).
Figure 5.G. mellonella larva with an open body cover immersed in Ringer's buffer spread on a plate with Sylgard's silicon elastomer. (A) overview; (B and C) internal organs seen under a stereoscopic microscope; (D) dissection of the fat body; (E) dissection of the gut; (F) dissected gut. Letter designations: AS - air sacs; Cu - cuticle; FB - fat body; G - gut; SG - spinning glands.
Examples of an arms race between insect hosts and pathogensPlease s.
| Possible host's strategies (insect) |
| Possible pathogen's strategies (bacteria or fungi) |
| Production of a sclerotic cuticle containing chitin, a layer of lipids and waxes that protect the insect against the entry of pathogens into the body (Klowden |
| Synthesis of cuticle-degrading enzymes: lipases, proteases and chitinases (Butt |
| Recognition of the pathogen and activation of the immune response |
| Reduction of the number of pathogen-associated molecular patterns, which prevents the effective recognition, resulting in minimisation of the immune response (Wanchoo, Lewis and Keyhani |
| Coordinated reaction of the immune system, aimed at destroying pathogen cells |
| Destruction of host organs and tissues, especially those producing immune peptides, through the action of proteolytic enzymes |
| Synthesis of antimicrobial peptides |
| Secretion of proteases destroying antimicrobial peptides (Ortiz-Urquiza and Keyhani |
|
| Modification of the cell wall to hinder binding of antimicrobial peptides. Active removal of peptides from the cell (Joo, Fu and Otto | |
| Synthesis of protease inhibitors (Wedde |
| What would the further pathogens' answer be? |
| Synthesis of detoxification proteins (Vilcinskas |
| Synthesis of toxic secondary metabolites (Ortiz-Urquiza and Keyhani |
| Phagocytosis and encapsulation |
| Avoidance of recognition by hemocytes (Pendland, Hung and Boucias |
| Possible enhanced resistance upon repeated contact with a given pathogen, ability to “remember” previous infections (Chambers and Schneider |
| Repeated infectionsWhat would the further pathogens' answer be? |
The use of G. mellonella for in vivo investigations of compounds against human pathogens: reports published in the first half of 2020.
| Antibacterial compounds | Antifungal compounds |
| β-lactam antibiotics against | Itraconazole against |
| Kyotorphins against | |
| Ceftazidime-avibactam alone and in combination with polymyxin against | Lactoferrin and amphotericin B against |
| Inhalable nanosuspensions consisting of C109 nanocrystals stabilised with D-α-tocopheryl polyethylene glycol 1000 succinate against | EeCentrocin 1 derived peptide EC1-17KV against |
| 4-chloro-3-nitrophenyldifluoroiodomethyl sulfone against | |
| Aptamer DNA scaffolded silver nanoclusters as an antimicrobial agent for treating | Chelerythrine against |
| Liposomal nanoparticles incorporating anidulafungin against | |
| Tedizolid against | Ribavirin alone and in combination with fluconazole against |
|
| Caspofungin, fluphenazine and their combination against |
| Cecropin A in combination with nalidixic acid against uropathogenic | Activity of copper(II), manganese(II) and silver(I) 1,10-phenanthroline chelates against |
| Polyketides against | |
| Minocycline-azole combinations against pathogenic fungi including | |
| Micocycline in combination with fluconasole against fluconasole-resistant | |
| Voriconazole against cryptococcosis infections (De Castro Spadari |